pubmed-article:9564682 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9564682 | lifeskim:mentions | umls-concept:C0011206 | lld:lifeskim |
pubmed-article:9564682 | lifeskim:mentions | umls-concept:C0041491 | lld:lifeskim |
pubmed-article:9564682 | lifeskim:mentions | umls-concept:C0679109 | lld:lifeskim |
pubmed-article:9564682 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
pubmed-article:9564682 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
pubmed-article:9564682 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:9564682 | pubmed:dateCreated | 1998-6-8 | lld:pubmed |
pubmed-article:9564682 | pubmed:abstractText | Recently, an association has been reported between schizophrenia and a rare allele containing 10-repeats (A10) of a polymorphic tetranucleotide motif in the first intron of the tyrosine hydroxylase (TH) gene. The present association analysis tested the hypothesis that the A10 candidate allele confers vulnerability to alcohol-withdrawal delirium with visual hallucinations. The genotype of the TH tetranucleotide polymorphism was assessed in 204 German controls and 311 German alcohol-dependent subjects, including 63 alcoholics with a history of visual hallucinations during withdrawal delirium. The frequency of the A10 allele was significantly increased in the alcoholics with withdrawal delirium (3.2%) compared with that in the controls (0.5%; Fisher's exact test: P = 0.03, two-tailed; OR (A10+) = 6.85, 95% confidence interval: 1.52-30.79). The possible allelic association suggests that allelic variation at the TH locus mediates vulnerability to alcohol-withdrawal delirium in a small proportion of alcohol-dependent subjects. | lld:pubmed |
pubmed-article:9564682 | pubmed:language | eng | lld:pubmed |
pubmed-article:9564682 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9564682 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9564682 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9564682 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9564682 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9564682 | pubmed:issn | 0955-8829 | lld:pubmed |
pubmed-article:9564682 | pubmed:author | pubmed-author:SchmidtL GLG | lld:pubmed |
pubmed-article:9564682 | pubmed:author | pubmed-author:HarmsHH | lld:pubmed |
pubmed-article:9564682 | pubmed:author | pubmed-author:Rommelspacher... | lld:pubmed |
pubmed-article:9564682 | pubmed:author | pubmed-author:SanderTT | lld:pubmed |
pubmed-article:9564682 | pubmed:author | pubmed-author:HoeheMM | lld:pubmed |
pubmed-article:9564682 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9564682 | pubmed:volume | 8 | lld:pubmed |
pubmed-article:9564682 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9564682 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9564682 | pubmed:pagination | 13-7 | lld:pubmed |
pubmed-article:9564682 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:9564682 | pubmed:meshHeading | pubmed-meshheading:9564682-... | lld:pubmed |
pubmed-article:9564682 | pubmed:meshHeading | pubmed-meshheading:9564682-... | lld:pubmed |
pubmed-article:9564682 | pubmed:meshHeading | pubmed-meshheading:9564682-... | lld:pubmed |
pubmed-article:9564682 | pubmed:meshHeading | pubmed-meshheading:9564682-... | lld:pubmed |
pubmed-article:9564682 | pubmed:meshHeading | pubmed-meshheading:9564682-... | lld:pubmed |
pubmed-article:9564682 | pubmed:meshHeading | pubmed-meshheading:9564682-... | lld:pubmed |
pubmed-article:9564682 | pubmed:meshHeading | pubmed-meshheading:9564682-... | lld:pubmed |
pubmed-article:9564682 | pubmed:meshHeading | pubmed-meshheading:9564682-... | lld:pubmed |
pubmed-article:9564682 | pubmed:meshHeading | pubmed-meshheading:9564682-... | lld:pubmed |
pubmed-article:9564682 | pubmed:meshHeading | pubmed-meshheading:9564682-... | lld:pubmed |
pubmed-article:9564682 | pubmed:meshHeading | pubmed-meshheading:9564682-... | lld:pubmed |
pubmed-article:9564682 | pubmed:meshHeading | pubmed-meshheading:9564682-... | lld:pubmed |
pubmed-article:9564682 | pubmed:meshHeading | pubmed-meshheading:9564682-... | lld:pubmed |
pubmed-article:9564682 | pubmed:year | 1998 | lld:pubmed |
pubmed-article:9564682 | pubmed:articleTitle | Possible allelic association of a tyrosine hydroxylase polymorphism with vulnerability to alcohol-withdrawal delirium. | lld:pubmed |
pubmed-article:9564682 | pubmed:affiliation | Department of Psychiatry, University Hospital Benjamin Franklin, Free University of Berlin, Germany. | lld:pubmed |
pubmed-article:9564682 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9564682 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |